ATRA
Price
$5.87
Change
-$0.26 (-4.24%)
Updated
Apr 3, 04:58 PM (EDT)
Capitalization
34.68M
PHAT
Price
$5.00
Change
-$0.49 (-8.93%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
348.18M
39 days until earnings call
Ad is loading...

ATRA vs PHAT

Header iconATRA vs PHAT Comparison
Open Charts ATRA vs PHATBanner chart's image
Atara Biotherapeutics
Price$5.87
Change-$0.26 (-4.24%)
Volume$100
Capitalization34.68M
Phathom Pharmaceuticals
Price$5.00
Change-$0.49 (-8.93%)
Volume$11.28K
Capitalization348.18M
ATRA vs PHAT Comparison Chart
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. PHAT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Hold and PHAT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ATRA: $5.92 vs. PHAT: $5.00)
Brand notoriety: ATRA and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 48% vs. PHAT: 98%
Market capitalization -- ATRA: $34.68M vs. PHAT: $348.18M
ATRA [@Biotechnology] is valued at $34.68M. PHAT’s [@Biotechnology] market capitalization is $348.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATRA and PHAT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 4 TA indicator(s) are bullish while PHAT’s TA Score has 4 bullish TA indicator(s).

  • ATRA’s TA Score: 4 bullish, 5 bearish.
  • PHAT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ATRA and PHAT are a bad buy in the short-term.

Price Growth

ATRA (@Biotechnology) experienced а -13.95% price change this week, while PHAT (@Biotechnology) price change was -25.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

ATRA is expected to report earnings on Aug 12, 2024.

PHAT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($348M) has a higher market cap than ATRA($34.7M). PHAT YTD gains are higher at: -38.424 vs. ATRA (-53.944). ATRA has higher annual earnings (EBITDA): -75.75M vs. PHAT (-261.52M). PHAT has more cash in the bank: 297M vs. ATRA (42.5M). ATRA has less debt than PHAT: ATRA (43.8M) vs PHAT (202M). ATRA has higher revenues than PHAT: ATRA (129M) vs PHAT (55.3M).
ATRAPHATATRA / PHAT
Capitalization34.7M348M10%
EBITDA-75.75M-261.52M29%
Gain YTD-53.944-38.424140%
P/E RatioN/AN/A-
Revenue129M55.3M233%
Total Cash42.5M297M14%
Total Debt43.8M202M22%
FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATRAPHAT
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LVTX1.270.02
+1.60%
LAVA Therapeutics NV
PMT14.58-0.03
-0.21%
PennyMac Mortgage Investment Trust
EEFT108.15-0.76
-0.70%
Euronet Worldwide
ARL11.45-0.11
-0.95%
American Realty Investors
ALL205.43-2.07
-1.00%
Allstate Corp (The)

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATRA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+2.00%
IKNA - ATRA
72%
Closely correlated
N/A
ABCZF - ATRA
53%
Loosely correlated
N/A
RAPT - ATRA
37%
Loosely correlated
-0.85%
PHAT - ATRA
36%
Loosely correlated
+7.23%
ABCL - ATRA
34%
Loosely correlated
+6.22%
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with VERA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then VERA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-8.93%
VERA - PHAT
43%
Loosely correlated
-3.52%
TNFA - PHAT
39%
Loosely correlated
+0.02%
ATRA - PHAT
36%
Loosely correlated
-3.43%
SCPH - PHAT
32%
Poorly correlated
-8.00%
AKRO - PHAT
32%
Poorly correlated
-4.65%
More